Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Fred R. Hirsch

Folylpoly-Glutamate Synthetase Expression Is Associated With Tumor Response and Outcome From Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma

Journal of Thoracic Oncology

English

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

Journal of Thoracic Oncology

English

Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment Naïve Lesions

Journal of Thoracic Oncology

English

The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

Journal of Thoracic Oncology

English

The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion From the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Journal of Thoracic Oncology

English

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK

Journal of Thoracic Oncology

English

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations

English

CD44 Facilitates Epithelial to Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer

Molecular Cancer Therapeutics

Cancer Research

Oncology

2018

English

EGFR Expression and Survival in Patients Given Cetuximab and Chemoradiation for Stage III Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0324

Radiotherapy and Oncology

English

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Fred R. Hirsch

Folylpoly-Glutamate Synthetase Expression Is Associated With Tumor Response and Outcome From Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment Naïve Lesions

The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion From the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations

CD44 Facilitates Epithelial to Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer

EGFR Expression and Survival in Patients Given Cetuximab and Chemoradiation for Stage III Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0324

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer